Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mehmet Polatli

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Respiratory Medicine|January 8, 2013
Chronic obstructive pulmonary disease and associated healthcare resource consumption in the Middle East and North Africa: the BREATHE studyMehmet Polatli, Ali Ben Kheder, Siraj Wali, et al.
International Journal of Chronic Obstructive Pulmonary Disease|December 4, 2023
An Alpha-1 Antitrypsin Deficiency Screening Study in Patients with Chronic Obstructive Pulmonary Disease, Bronchiectasis, or Asthma in TurkeySeda Tural Onur, Antonino Natoli, Bettina Dreger, et al.
Tuberkuloz Ve Toraks|May 13, 2014
[Treatment of severe asthma: expert opinion]Haluk Türktaş, Sevim Bavbek, Gülfem Celik, et al.
BMC Pulmonary Medicine|August 30, 2025
Impact of COVID-19 and lockdown on outcomes of COPD patients in Turkey: lessons for the futureDemet Polat Yulug, Elif Sen, Aylin Ozgen Alpaydin, et al.
Tuberkuloz Ve Toraks|April 27, 2024
Asthma-chronic obstructive pulmonary disease overlap: Results from a national-multicenter studyGülfem Elif Çelik, Ömür Aydin, Elif Şen, et al.
Medicine|November 29, 2024
Readmission rates within the first 30 and 90 days after severe COPD exacerbations (RACE study)Oya Baydar Toprak, Mehmet Polatli, Ayşe Baha, et al.
International Journal of Chronic Obstructive Pulmonary Disease|December 16, 2025
Validation Study of Rome Criteria for Assessing COPD Exacerbation Severity and Predicting Clinical Outcomes: Turkish Thoracic Society COPD AssemblyAyse Baha, Caner Baysan, Sibel Atis Nayci, et al.
Respiratory Medicine|December 1, 2024
Factors influencing the prescription of add-on long-acting muscarinic antagonists in real-world asthma management: Insights from a national registryBilun Gemicioglu, Derya Gokmen, Ali Can, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|April 16, 2025
Distinct characteristics of asthma overlap phenotypes: Insights from the Turkish adult asthma registrySecil Kepil Ozdemir, Bilun Gemicioglu, Fusun Yildiz, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|November 27, 2025
Identifying future risk factors of uncontrolled asthma control: the TAAR study perspectiveNurgul Bozkurt, Oznur Abadoglu, Ayse Bilge Ozturk Onaran, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Respiratory Medicine|January 8, 2013
Chronic obstructive pulmonary disease and associated healthcare resource consumption in the Middle East and North Africa: the BREATHE studyMehmet Polatli, Ali Ben Kheder, Siraj Wali, et al.
International Journal of Chronic Obstructive Pulmonary Disease|December 4, 2023
An Alpha-1 Antitrypsin Deficiency Screening Study in Patients with Chronic Obstructive Pulmonary Disease, Bronchiectasis, or Asthma in TurkeySeda Tural Onur, Antonino Natoli, Bettina Dreger, et al.
Tuberkuloz Ve Toraks|May 13, 2014
[Treatment of severe asthma: expert opinion]Haluk Türktaş, Sevim Bavbek, Gülfem Celik, et al.
BMC Pulmonary Medicine|August 30, 2025
Impact of COVID-19 and lockdown on outcomes of COPD patients in Turkey: lessons for the futureDemet Polat Yulug, Elif Sen, Aylin Ozgen Alpaydin, et al.
Tuberkuloz Ve Toraks|April 27, 2024
Asthma-chronic obstructive pulmonary disease overlap: Results from a national-multicenter studyGülfem Elif Çelik, Ömür Aydin, Elif Şen, et al.
Medicine|November 29, 2024
Readmission rates within the first 30 and 90 days after severe COPD exacerbations (RACE study)Oya Baydar Toprak, Mehmet Polatli, Ayşe Baha, et al.
International Journal of Chronic Obstructive Pulmonary Disease|December 16, 2025
Validation Study of Rome Criteria for Assessing COPD Exacerbation Severity and Predicting Clinical Outcomes: Turkish Thoracic Society COPD AssemblyAyse Baha, Caner Baysan, Sibel Atis Nayci, et al.
Respiratory Medicine|December 1, 2024
Factors influencing the prescription of add-on long-acting muscarinic antagonists in real-world asthma management: Insights from a national registryBilun Gemicioglu, Derya Gokmen, Ali Can, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|April 16, 2025
Distinct characteristics of asthma overlap phenotypes: Insights from the Turkish adult asthma registrySecil Kepil Ozdemir, Bilun Gemicioglu, Fusun Yildiz, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|November 27, 2025
Identifying future risk factors of uncontrolled asthma control: the TAAR study perspectiveNurgul Bozkurt, Oznur Abadoglu, Ayse Bilge Ozturk Onaran, et al.
Pageof 4